Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluid by Ruth Mokgokong et al.
ION CHANNELS, RECEPTORS AND TRANSPORTERS
Ion transporters in brain endothelial cells that contribute
to formation of brain interstitial fluid
RuthMokgokong & ShanshanWang &Caroline J. Taylor &
Margery A. Barrand & Stephen B. Hladky
Received: 7 August 2013 /Revised: 24 August 2013 /Accepted: 24 August 2013 /Published online: 11 September 2013
# The Author(s) 2013. This article is published with open access at Springerlink.com
Abstract Ions and water transported across the endothe-
lium lining the blood–brain barrier contribute to the fluid
secreted into the brain and are important in maintaining
appropriate volume and ionic composition of brain inter-
stitial fluid. Changes in this secretion process may occur
after stroke. The present study identifies at transcript and
protein level ion transporters involved in the movement
of key ions and examines how levels of certain of these
alter following oxidative stress. Immunohistochemistry
provides evidence for Cl−/HCO3
− exchanger, AE2, and
Na+, HCO3
− cotransporters, NBCe1 and NBCn1, on
brain microvessels. mRNA analysis by RT-PCR reveals
expression of these transporters in cultured rat brain
microvascular endothelial cells (both primary and immor-
talized GPNT cells) and also Na+/H+ exchangers, NHE1
(primary and immortalized) and NHE2 (primary cells
only). Knock-down using siRNA in immortalized GPNT
cells identifies AE2 as responsible for much of the Cl−/
HCO3
− exchange following extracellular chloride remov-
al and NHE1 as the transporter that accounts for most of
the Na+/H+ exchange following intracellular acidification.
Transcript levels of both AE2 and NHE1 are increased
following hypoxia/reoxygenation. Further work is now
required to determine the localization of the bicarbonate
transporters to luminal or abluminal membranes of the
endothelial cells as well as to identify and localize
additional transport mechanisms that must exist for K+
and Cl−.
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Correct function of cells in the brain is dependent on the
maintenance of suitable volume and ionic composition of
the interstitial fluid (ISF) between the cells. This is
determined by movement of ions and water in and out
of cells, across the blood brain barrier and between ISF
and cerebrospinal fluid (CSF). Water follows the osmotic
gradients determined by the concentrations of the solutes,
most importantly in the ISF, Na+ and Cl−. At steady state
when the cells have constant composition, there is no net
movement of ions into or out of them, and interstitial
concentrations are thus determined by blood–brain trans-
fer and exchanges with the CSF. Experiments where
tracers are added have shown that both routes are impor-
tant [21, 22, 55]. The transport of ions and water across
endothelial cells forming the blood–brain barrier repre-
sents net secretion of fluid from blood to brain. This net
secretion must be balanced by a net transfer of interstitial
fluid out of the brain into the CSF, which is estimated to
be between 10 and 30 % of the total rate of production
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of CSF, with the remainder ascribed to the choroid plexuses
[1, 15–17, 21, 46, 57, 74].1
Secretion of fluid by the blood–brain barrier must also be
involved in local brain tissue swelling, i.e. focal oedema.
Tissue volume increases must reflect either increased secre-
tion or maintained secretion with decreased net rate of remov-
al of fluid from the region to the CSF [67]. If there were to be
changes in production or outflow of CSF, this would involve
changes in fluid volume in spaces outside the brain parenchy-
ma and so be associated primarily with hydrocephalus. Thus,
to understand normal homeostasis of brain interstitial fluid
and its failures, e.g. after ischaemic stroke with or without
reperfusion, it is essential to understand the secretion process
at the blood–brain barrier.
The mechanism of secretion of Na+ and Cl− across the
endothelial cells that line the blood vessels forming the
blood–brain barrier is known in broad outline (for a review,
see [52]). Na+ and Cl− enter the endothelial cells largely via a
Na+, K+, 2 Cl− cotransporter, NKCC1, located in the luminal
(blood facing) membrane [26, 54, 72], while the Na+ leaves
these cells largely via the Na+, K+–ATPase, the Na+ pump,
located in the abluminal (brain facing) membrane [5, 6, 25, 26,
48, 65]. The exit route for Cl− is unknown: possibilities
include anion channels and K+, Cl− cotransporters.
For HCO3
− the major evidence for its mechanism of trans-
port is the demonstration in cultured rat brain endothelial cells
that under ambient conditions there is both Na+, HCO3
−
cotransport that alkalinizes the cells and Na+-independent
Cl−/HCO3
− exchange that acidifies the cells, these occurring
at comparable rates for intracellular pH (pHi) near 7.1 [49, 76].
Thus, if Na+, HCO3
− cotransport were to be primarily at the
luminal, blood-facing, membrane and the Cl−/HCO3
− ex-
change at the abluminal, brain-facing, membrane, then there
would be net secretion of HCO3
− into the brain. Combined
activity of carbonic anhydrase [27, 76] with Na+/H+ exchange
produces the same result as Na+, HCO3
− cotransport, but at pHi
above 7 the rate would be much less [49, 76]. Only at lower
pHi, e.g. 6.5, does Na
+/H+ exchange become dominant [49].
The molecular identities of the transporters likely to move
HCO3
− at the blood–brain barrier have not so far been
determined. Brain endothelial cells are known to express
appropriate DIDS-sensitive SLC4A transporters. The cells
also express NHE1 and NHE2 whose properties are suitable
for the Na+/H+ exchange [41, 68, 76].
The present study identifies at transcript and protein level
the ion transporters that could account for some of the activ-
ities observed. Immunohistochemistry provides clear evi-
dence for AE2 and indications for NBCn1 and NBCe1 in
the microvessels. Results from knock-down experiments
using siRNA in cells of the GPNT brain endothelial cell line
indicate that AE2 is responsible for the major part of the Cl−/
HCO3
− exchange observed when Cl- is removed from the
external solution and that NHE1 accounts for most of the
Na+/H+ exchange observed following intracellular acidifica-




Paraffin-embedded tissue Brain and kidney were fixed by
perfusion of halothane-anaesthetized animals via the abdomi-
nal aorta with 4 % paraformaldehyde in 0.1 M cacodylate
buffer, pH 7.4, according to the protocol of Praetorius [58].
Each organ was then cut into two equal halves, dehydrated
using increasing concentrations of ethanol, embedded in par-
affin and cut into 2 μM sections using a rotary microtome
(Leica, Heidelberg, Germany). Sections were incubated in
xylene overnight before staining. Initial rehydration was car-
ried out by exposing slides to decreasing concentrations of
ethanol. Endogenous peroxidase activity was blocked by
30 min of incubation in 0.5 % H2O2 in absolute methanol.
Some sections were exposed to 0.1% sodium dodecyl sulphate
for 30 min prior to antigen retrieval that involved boiling in
1 mM Tris, pH 9, supplemented with 0.5 mM EGTA for
13 min. Non-specific binding was limited by exposure to
50 mM NH4Cl and blockade in phosphate-buffered saline
(PBS) supplemented with 1 % bovine serum albumin (BSA),
0.05 % saponin and 0.2 % gelatine. Sections were incubated at
room temperature for 2 h, with the primary antibodies diluted
in PBS supplemented with 0.1 % BSA and 0.3 % Triton-X-
100, and after washing incubated with horseradish peroxidase
conjugated goat anti-rabbit or goat anti-mouse IgG (Dako,
Denmark) diluted in the same buffer. The peroxidase stain
was developed using 0.05 % 3,3′-diaminobenzidine
tetrahydrochloride (DAB) dissolved in PBS with 0.1 %
H2O2. Mayers haemotoxylin was used as a counterstain. Tis-
sue sections were dehydrated and mounted in hydrophobic
Eukitt mounting medium (O. Kindler, Freiburg, Germany).
Microscopy was performed on a Leica DMRE bright-field
microscope equipped with a Leica DM300 digital camera.
1 The mechanisms by which ions and water exchange between ISF and
CSF have not been fully established. When viewed over distances less
than a few hundred microns, movements of solutes and water within the
ISF appear as diffusion (for reviews, see [21] and [73]). Viewed over
larger distances, there is a superimposed, convective component, which
can occur both towards and away from CSF and is primarily localized to
the perivascular spaces surrounding blood vessels larger than capillaries
[1, 15–17, 32, 33]. The uncertainty concerns the relative importance of
convection and whether or not there is continuous circulation of fluid and
solutes across the outer surfaces of the brain from CSF into ISF and back
to CSF [1, 32, 33]. Such circulation may be very important for the
delivery of intrathecally administered drugs to within diffusion distance
of their targets (see e.g. [30]) but does not alter the need for a net efflux of
ions and water to CSF to balance secretion across the blood–brain barrier.
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Frozen tissue Whole rat brains were ‘snap’-frozen in
isopentane at −18 °C on dry ice and stored at −80 °C.
Twenty-micrometre sections cut on a cryostat were thaw-
mounted onto Vectabond™ (Vector Laboratories) coated
slides, fixed in methanol at −20 °C for 2 min, and
rehydrated in Tris-buffered saline (TBS, 50 mM Tris–
HCl, pH 7.6, 150 mM NaCl) containing 0.2 % (v /v )
Tween20 (TBS/Tween), and non-specific binding sites
were blocked with 50 μg ml−1 BSA in TBS/Tween
before application of the first primary antibody in
blocking solution for 1 h at room temperature. Control
slides were exposed for the same length of time but to
blocking solution alone. Slides were then washed well
and treated for 1 h at room temperature with the second-
ary antibody mixture containing Alexa Fluor™ 488 goat
highly cross-absorbed anti-mouse IgG (H+L) conjugate
at 1:50 (40 μg/mL) and Alexa Fluor™ 594 goat highly
cross-absorbed anti-rabbit IgG (H+L) conjugate at 1:150
(13.33 μg/mL) (Molecular Probes, Portland, OR, USA).
Sections were then washed well and mounted in
glycerol/PBS (9:1v /v ) containing an anti-fading agent
(DABCO at 2.5 mg ml−1) and visualised by fluorescence
microscopy.
An SDS epitope unmasking procedure was carried out for
detection of both AE1 and AE2 [11]. Without this treatment,
SA6 antibody stains mainly AE1, whereas the antibody reacts
with both AE1 and AE2 following epitope unmasking. Brief-
ly, the procedure involves fixing the sections in a solution
containing 4 g paraformaldehyde, 2.739 g L -lysine and
0.428 g sodium metaperiodate in 200 ml phosphate buffer,
pH 7.4, for 30 min at room temperature or immersion-fixing
overnight at 4 °C. The sections were then washed and
rehydrated in PBS containing 0.2 % (v /v ) Tween-20 and
incubated with 10 mg ml−1 sodium dodecyl sulphate in the
same buffer for 4 min before treatment with primary and
secondary antibodies as described earlier. Previous studies
using this method have allowed immunolocalization of AE2
in basolateral membranes of several rat kidney tubular epithe-
lial cell types [2] and on the basolateral membrane of epithelial
cells in the initial segment and intermediate zone of the rat
epididymis [35].
Sections were visualised by fluorescence microscopy, with
light being provided either by a mercury arc lamp (Zeiss
Axioskop) or a scanning confocal laser (Biorad Micro-
Radiance). With the Bio-Rad system, sequential images were
obtained (Kalman average of eight to ten individual scans) and
the two parent images were merged using Lasersharp software.
Antibodies The antibodies used with thin sections cut from
wax-embedded tissue are listed in Table 1. For the work with
thick sections cut from frozen tissue, the same antibodies were
used for AE2, AQP4 and NBCe1. Other antibodies used with
thick sections are listed in Table 2.
Isolation of brain microvessels and endothelial cell culture
Microvessel fragments were isolated from rat brain tissue
according to a method described previously [3, 63]. Endothe-
lial cells were grown out from these microvessels in collagen-
coated flasks and maintained in a medium containing Ham's
F-10 medium with 10 % (v /v ) foetal bovine serum (FBS),
75 μg/mL endothelial cell growth supplement (First Link,
(UK), Ltd., Birmingham, UK), 80 μg/mL heparin, 5 μg/mL
vitamin C, 2 mM L-glutamine, 100 U/ mL penicillin and
100 μg/mL streptomycin. Cells were used at passages 2–4.
The GPNT cell line [62] is an immortalised rat brain
endothelial cell line derived from the GP8 cell line [29]. Cells
used in this study were a kind gift from Dr. I. Romero (Open
University, Milton Keynes, UK). Cells were maintained on
collagen-coated flasks in a 1:1 mix of Ham's F-10: MEM-α
supplemented with 10 % (v /v ) FBS, 2 mM L-glutamine, 100
U/mL penicillin, 100 μg/mL streptomycin, 2 μg/ mL basic
fibroblast growth factor (First Link) and 5 μg/mL puromycin.
Application of oxidative challenge
Cells grown to confluency inmultiwell plates were exposed to
oxidative challenge in one of two ways as described in [63],
either by direct application of medium containing 200 μM
H2O2 to each well or by applying hypoxic conditions to cells
for 6 h followedwith reoxygenation as described [63]. For this
latter method, cells were treated with medium that had been
pre-bubbled with 95%N2 in CO2 for 3 min and then placed in
a hypoxia chamber (Bilups-Rothenburg, www.brincubator.
com) flushed with a mixture of 95 % air/5 % CO2 and
95 % N2/5 % CO2 and maintained at 1 % O2 for 6 h. Cells
were reoxygenated by feeding with fresh, fully oxygenated
medium and were replaced into the incubator for the times
indicated before analysis.
RT-PCR analysis and reference gene selection
Total cellular RNA was isolated using TriPure Isolation Re-
agent (Roche, Derbyshire, UK) and cDNAwas generated by
reverse transcription using random hexamers as described
previously [63]. Fragments specific to the rat genes of interest
were then amplified by PCR using SensiMix (Quantace Ltd,
Watford, UK) containing SYBR green and the appropriate
primer pairs (see Table 3). Reactions were run on Rotor-
gene 3000 (Corbett Research, Sydney, NSW, Australia). Ther-
mal cycling conditions included initial denaturation for 10min
at 95 °C followed by 45 cycles of 95 °C for 30 s, 55 °C for 30 s
and 72 °C for 30 s, with terminal elongation being performed
at 72 °C for 2 min with a melt curve analysis from 72 to 99 °C.
Data were analysed using the comparative quantitation option
in Rotor-gene 3000 software (Corbett Research). As identified
by and described in Robertson et al. [63], the reference gene
Pflugers Arch - Eur J Physiol (2014) 466:887–901 889
most suitable for H2O2 exposure experiments was beta-actin
and for hypoxia/reoxygenation it was hypoxanthine-guanine
phosphoribosyltransferase.
Luciferase reporter gene assay
To detect the activation of NHE1 promoter, a construct
(kindly donated by Dr. Katarzyna Kania, Polish Academy
of Sciences, Lodz, Poland) containing a NHE1-specific
gene promoter sequence inserted into the pGL4.10[luc2]
vector was transfected by electroporation using the
Amaxa endo t h e l i a l t r a n s f e c t i o n k i t ( Lon z a ,
Basel, Switzerland). A vector encoding a secretable form
of alkaline phosphatase (pCMV-SEAP) under the control
of a cytomegalovirus-derived promoter was co-transfected
as described in Robertson et al. [63]. Following electro-
poration, cells were divided between six and nine wells of
24-well plates and maintained in medium for 24 h before
treatment with hypoxia/reoxygenation as described earlier.
After the requisite treatment times, the medium was
harvested for alkaline phosphatase activity and the cells
were analysed for luciferase activity, with values being
normalised to the alkaline phosphatase activity as described
previously [63].
Use of siRNA targeted against AE2 or NHE1
siRNA transfection mixes were prepared as follows: 50 nM of
the siRNA duplexes (Qiagen) (sequences shown below) was
diluted in 100 μl Opti-MEM with gentle mixing, 3 μl of
INTERFERinTM (Polyplus transfection), then added to the
solutions and allowed to incubate for 10 min. To apply to
GPNT cells already grown to ~50 % confluency in 24 well
plates, the growth medium was removed from each well and
0.5 ml fresh medium was added. A total of 100 μl of the
siRNA mix was then added and the plate was incubated at
37 °C. For RNA, cells were harvested after 24 h, and for
fluorimetry or immunocytochemistry cells were trypsinised
after 48 h and plated on glass coverslips.
Two duplexes were targeted against AE2:
Sequence 1, sense r(GCG CCA ACA UGG ACU ACC
A)dTdT and antisense r(UGG UAG UCC AUG UUG
CGC C)dTdG
Sequence 2, sense r(GCC UAA CAC UGC CUU GCU
A)dTdT and antisense e(UAG CAA GGC AGU GUU
AGG C)dTdG
One duplex was targeted against NHE1:
Sequence 3, sense 5′CCGCAATTTGACCAACTTATA-3′
and antisense 5′-UAUAAGUUGGUCAAUUGCGC-3′
Table 1 Antibodies used with




AE2 Seth Alper, Harvard Alper SL et al., 1997 [2]
rkNBC1 (Slc4a4, NBCe1) Aarhus Maunsbach AB et al., 2000 [45]
NBCn1 (Slc4a7) Aarhus Kwon TH et al., 2002 [40]
Vacuolar H+–ATPase Aarhus Pushkin A et al., 1999b [61]
Pushkin A et al., 2000 [60]
Na+, K+–ATPase Aarhus Kashgarian M et al., 1985 [37]
AQPl Aarhus Nielsen S et al., 1993 [51]
AQP4 Aarhus Terris J et al., 1995 [77]
PECAM (CD31) Chemicon
Table 2 Antibodies
used with thick sections
(the antibodies used
against AE2, AQP4 and
NBCe1 were the same as
in Table 1)
Antibody Raised in Source Reference
N1P1G (NHE1) Rabbit Josette Noel, Montreal Granger D et al., 2003 [28]
mNCBE 1139AP Rabbit Aarhus Praetorius J et al., 2004 [58]
ntNBCn1 2977AP Rabbit Aarhus Damkier H et al., 2006 [19]
ntNBCe2 7249AP Rabbit Walter Boron, Yale via Aarhus Bouzinova EVet al., 2005 [9]
NCBE Rabbit Aarhus Praetorius J et al., 2006 [59]
NDCBE Rabbit Aarhus Damkier HH et al., 2007 [20]
PECAM1 Mouse Chemicon
Alexa Fluor 594 Anti-rabbit IgG Goat Molecular Probes
Alexa Fluor 488 Anti-mouse IgG Goat Molecular Probes
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The All Stars (Alexfluor 488) scrambled siRNA sequence
information is unavailable due to proprietary rights (Qiagen).
Functional studies
Na+/H+ and Cl−/HCO3
− exchange activities were inferred
from measurements of intracellular pH, pHi. This was mea-
sured as described in detail by Taylor et al. [76] using the
fluorescent indicator 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-car-
boxyfluorescein (BCECF) introduced into cells via exposure
to membrane-permeant BCECF-AM. Fluorescence was excit-
ed alternately at a pH-insensitive wavelength 440 nm and a
pH-sensitive wavelength 502 nm, and the pH was calculated
from the ratio of the background-corrected emissions mea-
sured at 530 nm. A calibration curve for converting the ratio to
pH was determined for rat brain endothelial cells using a
combination of nigericin-high K+ and weak acid/weak base
null point methods [76].
Na+/ H+ exchange was assessed using an ammonium
prepulse as described previously [49, 76]. Briefly, cells were
exposed to 20 mM NH4Cl, replacing the same amount of
NaCl in the external Hepes-buffered solution (nominally
HCO3
− free) for 200 s followed by return to a fresh aliquot
of the original solution. During the exposure, pHi initially shifts
rapidly to a more alkaline value corresponding to diffusion into
the cells of NH3 and its combination there with H
+ to form
NH4
+. pHi then partly recovers, which, because the NH3 con-
centration is then constant, implies a further increase in NH4
+.
When the cells are returned toNH4Cl-free solution, all theNH4
+
exits as NH3, leaving behind H
+ that greatly reduces pHi. In the
nominal absence of HCO3
−, recovery is virtually abolished by
either replacement of external Na+ with NMDG+ or application
Table 3 Primers for the detection




Gene Primer pair sequence Accession number
Slc9a1, NHE1 5′-ATGTGGCTGGGAAACAAGAC-3′ NM_012652
5′-AGTGGTCCTCATCACCCAA-3′
Slc9a2, NHE2 5′-ACTGGGGTCACAACTTCTGG-3′ NM_012653
5′-TCCCTGTCTCTGCCATCTCT-3′
Slc9a3, NHE3 5′-ACAGAAGCGGAGGAATAGCA-3′ NM_012654
5′-TATCAATTCCTGCCCCAGAG-3′
Slc9a4, NHE4 5′-GGGAAGAACCATGAGTGGAA-3′ NM_173098
5′-GGGAAAAGGGTCAGAGGAAG-3′
Slc9a5, NHE5 5′-TGTCTTCTGACCCTCGCTCT-3′ NM_138858
5′-TACAGCCTGCCTCCTCTGTT-3′
Slc4a1, AE1 5′-GCTTCTGGCTTATCCTGCTG-3′ NM_012651
5′-AGCGGGTAGTCCTGGAAAAT-3′
Slc4a2, AE2 5′-GAGCCCTTCTGCTGAAACAC-3′ NM_017048
5′-CGCTCTCTATCCACCTCCAG-3′
Slc4a3, AE3 5′-AAAAGCCTGAAACTGCTGGA-3′ NM_017049
5′-GCCCTAGCTCGTGATAGTCG-3′
Slc4a4, NBCe1 5′-TAGCGACAACGACGATTCTG-3′ NM_053424
5′-TTGAGGCACGACTTTCACTG-3′
Slc4a5, NBCe2 5′-GTTCGTCTTGCCCAGTCTTC-3′ NM_212512
5′-TCATCAACTCCTGCGATCAG-3′
Slc4a7, NBCn1 5′-AAACATCACCACCGGAGAAG-3′ NM_058211
5′-TCTTCGAACTTCAGCCACCT-3′
Slc4a8, NDCBE 5′-ACGGGGATTGCCTACTCTCT-3′ NM_199497
5′-AGTCGCCACCAGGACAATAC-3′




β actin 5′-TGTCACCAACTGGGACGATA-3′ NM_031144
5′-AACACAGCCTGGATGGCTAC-3′
HPRT 5′-CTCATGGACTGATTATGGACAGGAC-3′ NM_012583
5′-GCAGGTCAGCAAAGAACTTATAGCC-3′ Jaulmes et al., 2006 [34]
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of 5 μM 5-(N-ethyl-N-isopropyl)amiloride (EIPA) [49, 76].
The NHE1 inhibitor, cariporide (HOE642), wasmade upwithin
3 h of use as a 100-mM stock in distilled water.
Cl−/ HCO3
− exchange was assessed from the increase in
pHi when external Cl
− was removed. This removal leads to a




Detection of transporters in rat brain
Immunohistochemical studies to detect the location of ion
transporters in rat brain were initially carried out using a panel
of antibodies selective for Na, K–ATPase, AE2, AQP4,
AQP1, NHE1, NHE3, NBCe1 and NBCn1 as shown in
Table 1. These were kindly supplied by Dr. Jeppe Praetorius.
The techniques followed those published by Praetorius and
collaborators and involved 2-μM sections cut from wax-
embedded rat brain. These were able to detect the transporters
concerned in choroid plexus or kidney, with examples shown
for the first three in Fig. 1. However, with the exception of
AQP4, which is known to be expressed at high levels in the
astrocyte end-feet that surround the microvessels [50], none of
the other antibodies produced detectable specific staining
around the microvessels in the brain slices. An antibody
against CD31, PECAM, which is known to be present in brain
microvessels, also failed to produce detectable staining in the
thin sections. It was concluded from this that though these
techniques were appropriate for localizing transporters that are
highly expressed, they were inadequate for detecting trans-
porters that are expressed at lower levels as may be the case in
or on the microvessel walls. Hence, these results indicated that
the ion transporters of interest must be expressed in brain and
the microvessels at levels lower than those found in the spe-
cialized transporting epithelia of choroid plexus and kidney.
To enhance the sensitivity of detection, immunohistochem-
istry using fluorescent secondary antibodies was applied to
thicker sections cut from frozen blocks. The advantage of
thicker sections is that a field of view will contain more
transporters, allowing easier detection; the disadvantage is that
spatial discrimination and resolution allowing structural fea-
tures to be displayed are inevitably lost. It was however
possible to locate blood vessels in the frozen sections using
an anti-PECAM antibody. This is illustrated in Fig. 1f for anti-
AQP4 and anti-PECAM antibodies raised in different species
and hence detectable with different secondary antibodies. The
fluorescence corresponding to the location of the AQP4 anti-
body (shown in red) is seen to surround that for the PECAM
antibody (shown in green).
This approach was applied to detect AE2, NBCe1 and
NBCn1 in frozen rat brain slices as shown in Fig. 2. To reveal
the presence of AE2, it was necessary to use an unmasking
procedure [11] before the application of the primary antibody
as described in “Methods” and the figure legend. With
unmasking, AE2 was seen to be distributed along the walls
of the microvessels (Fig. 2c, d). The antibody used to detect
AE2 also binds to AE1 within the red blood cells, which can
be seen clearly with or without unmasking (Fig. 2a–d). With
NBCn1, there is binding along the course of the vessels and
also to other components in the brain, while with NBCe1 the
same appears to occur but less clearly. Background staining
with the secondary antibodies alone was minor, i.e. less than
the diffuse staining seen in Fig. 2a, b. Immunohistochemistry
provides evidence for the presence of AE2, NBCn1 and
possibly NBCe1 on the microvasculature. No evidence was
found using these methods for NBCe2, NCBE (NBCn2) or
NDCBE protein along the microvessels consistent with either
no expression or low expression comparable to that seen on
the surrounding cells.
Evidence for ion transporter expression in cultured rat brain
endothelial cells
In order to explore the possible functional significance of the
ion transporters detected in the brain vascular endothelium, it
was necessary to undertake experiments on primary cultured
rat brain endothelial cells (RBECs) and on immortalized rat
brain endothelial cells (GPNTcells). To ensure that these cells
expressed the ion transporters detected in vivo, mRNA anal-
yses were firstly carried out.
As previously reported [76] for RBECs, compared to that
for NHE1, a relatively large amount of mRNA for AE2, ca.
sixfold less for AE3 and ca 100-fold less for AE1 was found.
Of the NBCs, NBCe1 and NBCn1 were most highly
expressed, NCBE and NDCBE somewhat less and NBCe2
ca. 80-fold less. In a more recent study where AEs were
compared in primary cultured RBECs and in cells of the
immortalized GPNT line, there was found to be less AE3
(relative to NHE1 in the same cell type) but somewhat more
AE2 than seen previously (see Fig. 3).
Expression of NHE 2–5 relative to NHE1 was also exam-
ined. Results are shown in Fig. 3 for RBECs and GPNT.
NHE2 mRNA is approximately 50-fold less than that of
NHE1 in the RBECs and at least 500-fold less prominent
relative to NHE1 in the GPNT cell line. Primers were validat-
ed using whole rat brain and whole rat kidney. They detected
NHE 2, 4 and 5 at more than 10 % of the level for NHE1 in
whole rat brain and detected NHE3 at the same level as NHE1
in whole rat kidney.
Experiments were also performed to determine whether
oxidative challenge might alter the expression of AE2 and
NHE1 and the activity of the NHE1 promoter. For this pur-
pose, GPNT cells were used, these being more readily ame-
nable to transfection of the reporter gene construct. Oxidative
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challenge was imposed by direct application of H2O2 or by
exposing the cells to 6 h of hypoxia, 1 % O2 and 5 % CO2 in
reduced serum medium, followed by 16 h of normoxia, 5 %
CO2 in air. As shown in Fig. 4, both types of challenge
significantly increased the expression of mRNA for AE2
and NHE1. Furthermore, using a luciferase reporter gene
construct, it was also shown that hypoxia/reoxygenation in-
creased the activity of the NHE1 promoter.
Evidence for ion transporter activity in cultured rat brain
endothelial cells
Having established the presence of mRNA for the above ion
transporters in cultured rat brain endothelial cells, studies were
undertaken to look for the functional activities of these trans-
porters. Procedures for detecting the activity of various types
of ion transporter in these cells were by monitoring changes in
pHi following various challenges which have been presented
earlier (Taylor, 2006; Nicola et al., 2008). Na+/H+ exchange
can be assayed from the rate of recovery of pHi after an acid
challenge imposed by transient exposure to NH4Cl for cells in
nominally bicarbonate-free medium. Cl−/HCO3
− exchange
can be assayed with cells in bicarbonate-buffered medium
by the rate of alkalinization observed when external Cl− is
removed. Na+/H+ exchange in RBECs has been shown to be
inhibited by EIPA with an IC50 near 0.5 μM (Taylor, 2006).
Inhibition of this exchange by cariporide in the GPNT cells is
shown in Fig. 5 where the IC50 is of the order of 1 μM. These
results are consistent with transport via NHE1. Cl−/HCO3
−
exchange in the RBECs was inhibited by DIDS and was not
affected by replacement of external Na+ using NMDG+ (Tay-





Fig. 1 Immunohistochemical detection of Na, K–ATPase, AE2, AQP4
and PECAM in rat brain. a , c and e Images obtained from 2-μm wax
embedded sections of brain stained for Na, K–ATPase, AE2 and AQP4
using the techniques previously employed to detect these proteins in
choroid plexus and kidney. The staining in c shows AE1 in red blood
cells within a larger blood vessel. b , d Images that illustrate positive
controls for Na, K–ATPase and AE2 in choroid plexus obtained in
parallel experiments conducted at the same time with the same materials.
Similarly, negative results for the microvessels and positive results for
appropriate controls were obtained with antibodies for NHE1, NHE2,
NHE3, AQP1, NBCe1 and NBCn1 (not shown). Only for AQP4 (shown
in e) was there a clear specific staining surrounding small blood vessels in
the thin brain sections. No staining was obtained in the thin sections with
antibody for PECAM (also known as CD31). By contrast, in a ~20-μM
frozen section from brain (f) stained for both PECAM (green) and AQP4
(red), a fluorescent signal for each is clearly evident following the course
of the blood vessels. Scale bars : black 10 μM, white 50 μM
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cells as can be seen in the controls for the experiments report-
ed in Fig. 7.
Another more specific method for identification of trans-
porters is provided by transfection of siRNA to reduce the
levels of transporter expressed. This technique was applied to
both RBECs and GPNT cells but was found to be more
effective in the immortalized GPNT cells. Using either of
two different siRNA constructs in the GPNT cells, it was
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Fig. 2 Confocal images of dual immunofluorescence staining for AE2 or
NBCe1 or NBCn1 together with PECAM in thick sections cut from
frozen brain segments. Measuring emission at >600 nm (shown as red)
with excitation only at 540 nm detects only one or another of the
transporters. With excitation at both 488 and 540 nM and emission
detection at 530±30 nm (shown as green) and >600 nm (shown as red)
PECAM is also detected. The sa6 antibody used in a–d recognises AE1
present in red blood cells, but after unmasking it also detects AE2 which
is seen to outline the vessel with little labelling elsewhere. In e and f , anti-
NBCn1 appears to label the blood vessels. In g and h , there is a
suggestion that anti-NBCe1 labelling also follows the blood vessels. In
these two frames, the red channel signal has been multiplied by 1.5. No
labelling distinguishable from the general background, which includes
staining of other cell types, was observed for anti-NBCe2, anti-NCBE,





















Fig. 3 Expression of NHEs and AEs at mRNA level in cultured rat brain
endothelial cells. Expression is shown relative to that for NHE1 in the
same cell type. Black bars for RBEC primary cultured cells; open bars
are for the GPNT immortalised cell line. Data are shown as mean ± s.e.m.
n =5 or 6 except for AE1 RBEC n=1, AE1GPNT n=1, AE3RBEC n =2
and AE3 GPNT n =3. In the GPNT cells, there was no detectable
expression of NHE2 in any experiment (NHE4 was not tested), while
for AE1 there was no detectable expression in either RBEC orGPNTcells
in two experiments. In GPNT cells, the expression of NHE1 relative to



















































Fig. 4 Effects of hypoxia/reoxygenation or exposure to hydrogen per-
oxide on expression of NHE1 and AE2 in GPNTcells. The first four bars
represent fold changes in AE2 or NHE1 mRNA levels and the last bar
shows fold change in NHE1 promoter activity relative to paired untreated
controls. H/R consisted of hypoxia at 1 % O2 for 6 h followed by
reoxygenation for 24 h. H2O2 was applied at 100 μM and left for 6 h.
Promoter activity was measured using luciferase reporter gene assay as
described in “Methods”. For H/R, expression levels were first normalized
to those for HPRT under the same conditions, and the ratios were then
compared between exposed cells and unexposed controls. For H2O2
exposure normalization was to expression of β-actin. These reference
genes have been shown previously to vary little with hypoxia/
reoxygenation and peroxide exposure, respectively [63]. All ratios shown
(mean ± s.e.m.) are significantly different from 1. From left to right: n =8,
p <0.01; n =5, p <0.05; n =4, p<0.01; n =4, p <0.05; n =6, p <0.05; t-
tests for the logs of the ratios compared to zero
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50 %, and using one siRNA construct, similar results were
obtained for NHE1 (see Fig. 6). That the reduction was not
due to the transfection process itself was demonstrated from
the lack of effect of transfection with the “AllStars” construct.
(Successful transfection of the fluorescent “AllStars” con-
struct was confirmed by flow cytometry; data not shown.)
Functional assays were undertaken in the transfected
GPNT cells with altered NHE1 and AE2 expression, and the
results are shown in Fig. 7. Example traces are given in
Fig. 7a–f and results are summarized in Fig. 7g, h. The two
siRNAs targeted at AE2 each produced a significant reduction
in Cl−/HCO3
− exchange (Fig. 7g), while the siRNA targeted
against NHE1 significantly reduced Na+/H+ exchange.
Discussion
Detection of transporters and their functions
To identify ion transporters on brain microvessels, immuno-



















cariporide concentration / µM 
Fig. 5 Inhibitory effect of cariporide on the rate of recovery of intracel-
lular pH (pHi) after an ammonium pulse in GPNT cells. pHi was mea-
sured using BCECF as described in “Methods”. Data are shown as mean
± s.e.m., n =4. The square symbol to the right indicates the rate of change
after complete replacement of external Na+ by NMDG+, which should
eliminate all transport via NHEs and is therefore taken as an estimate of
the limiting value for pHi changes in the presence of large cariporide
concentrations. The fitted curve corresponds to a IC50 for cariporide of






















Fig. 6 mRNA levels of AE2 (hashed bars) and of NHE1 (open bars) in
rat brain endothelial GPNT cells following treatment as described in
“Methods” without (control) or with either gene specific siRNA (siRNA)
or a scrambled sequence (“All Stars”). For AE2, where two different
sequences were used, data are given for each set of experiments (repre-
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Fig. 7 Functional effects of siRNA targeted against AE2 or NHE1 in
GPNT cells. AE function shown in a , c , e and g was assessed using the
initial rate of increase in intracellular pH induced by removing Cl− from
the extracellular medium. Cells were initially suspended in HCO3
−- and
Cl−-containing medium and after 1,150 s were transferred to medium in
which all Cl− was replaced by gluconate which stimulates HCO3
− influx
in exchange for Cl− efflux. The initial rate was calculated from the slope
of a straight line fitted by eye to the 100 s of the trace after Cl− removal.
NHE function shown in b , d , f and h was assessed using the initial rate of
increase in intracellular pH in nominally HCO3
−-free medium during
recovery after a 200-s exposure to 20 mM NH4Cl. The initial rate was
calculated from an exponential curve fitted to the data by least squares
minimization (example shown in f). a–f Examples of traces observed. a
and b show rates observed in cells not transfected with siRNA, c and d
are for cells transfected with “All Stars” siRNA that should have no
specific effect on transporter levels, and e and f are for cells transfected
with siRNA-1 specific for AE2 or siRNA-3 specific for NHE1, respec-
tively. Ratios of the rates observed for the transfected cells to those for the
corresponding paired controls are shown for AE2 in g and for NHE1 in h .
Data for the “All Stars” transfected cells are not significantly different
from control, while those for siRNA-1,2,3 are significantly less (n =3,
p <0.05, 0.05 and 0.01, respectively; t -test against 0 for the logarithm
of the ratio)
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sections was used initially. Such a method has been a key tool
in identifying the molecular species responsible for ion trans-
port in specialized epithelia such as kidney and choroid plexus
where high-resolution optical images clearly indicate
basolateral or apical locations for many of the transporters of
interest (see references in Table 1 and [18]). However, these
same procedures when used on brain sections (see Fig. 1)
were unable to detect any staining on microvessels, the rea-
sons almost certainly being that the lining endothelial cells are
very thin, with membranes lacking much folding and that the
transporters they express are at lower densities than in spe-
cialized epithelia.
To increase the sensitivity of detection, thick frozen sec-
tions were used, though this led to some loss of spatial
resolution. The positions of the microvessels within the sec-
tions were determined by labelling with an antibody to a
known endothelial cell marker, PECAM (CD31), together
with that to the transporter of interest. This dual-labelling
procedure provided clear evidence for AE2 protein along the
microvessels (Fig. 2). There was also labelling along
microvessels for NBCn1 and NBCe1. For the other trans-
porters investigated (NBCe2, NCBE, NDCBE and NHE1),
it was not possible to distinguish staining of microvessels
from that of surrounding parenchymal cells. While the
methods used here provide evidence for the presence of
AE2, NBCn1 and NBCe1 on brain microvessels, they are
incapable of localizing these transporters to specific mem-
branes. It is interesting to note that O'Donnell and coworkers
[41, 53] had to use immunoelectron microscopy in slices from
rat brains to locate NHE1 and NHE2 on luminal and
abluminal endothelial cell membranes with 65–75 % and
75–80 %, respectively, being found on the luminal side.
Functional activities of the transporters were investigated
using brain endothelial cells in culture. Previous studies on
cultured rat brain endothelial cells (RBECs) have detected
Na+, HCO3
− cotransport, Cl−/HCO3
− exchange and Na+/H+
exchange [49, 68, 76]. All of these activities were found also
in the GPNT-immortalized rat brain endothelial cells, which
were used here for transfection studies (see later discussion).
There was substantial expression at mRNA level of NBCn1
and NBCe1, the same Na+, HCO3
− cotransporters detected at
protein level in the brain slices. AE2 was also seen promi-
nently both at mRNA level in the cultured cells and as protein
in the slices and could account for the Cl−/HCO3
− exchange
observed in the cultured cells. NHE1 was seen prominently as
mRNA in both the RBEC and GPNT cells, while mRNA for
NHE2 was present at about 50-fold lower levels than NHE1 in
the RBECs. With RBECs [75], as Lam et al. [41] reported for
bovine cortical microvascular endothelial cells, both NHE1
and NHE2 were seen in western blots. As shown previously,
the Na+/H+ exchange observed in RBECs was inhibitable by
EIPA [68, 76, 79]. However, this does not distinguish between
the two NHE forms, so for a more precise identification, EIPA
was replaced by cariporide in the investigations with GPNT
cells (see Fig. 5). IC50 values for cariporide acting on NHE1
and NHE2 have been reported by others to be 0.03–3.4 μM
and 4.3–62 μM, respectively [44]. The IC50 value found here
for GPNTcells of 1.1 μM falls clearly within the lower range,
consistent with the mRNA observations of NHE1 but not
NHE2 in these cells. The value observed for bovine cortical
microvascular endothelial cells, 7 μM [41], may indicate both
NHE1 and NHE2 to be important in those particular cells.
The use of siRNA to depress levels of mRNA and func-
tion in cells provided another means of identifying the
molecular species responsible for the activities observed.
The effects of two siRNA sequences targeted against AE2
and one against NHE1 were assessed in the GPNT cells.
Each of the sequences directed against AE2 significantly
depressed both AE2 mRNA expression and the alkaliniza-
tion resulting from Cl−/HCO3
− exchange following the
removal of external chloride from HCO3
−-buffered medi-
um. Similarly, the sequence directed against NHE1 signif-
icantly depressed both NHE1 mRNA expression and the
alkalinization following an imposed acid load seen with
nominally HCO3
−-free medium. These data provide evi-
dence that AE2 and NHE1 not only are present but also
account at least in part for the activities in GPNT cells as
described earlier. However, it remains possible that in
RBEC cells where NHE2 is detectable, NHE2 may also
contribute.
Experiments were performed to determine whether oxida-
tive challenge might alter not only the expression of AE2 and
NHE1 but also the activity of the NHE1 promoter. For this
purpose, GPNT cells were used, these being more readily
amenable to the necessary transfection. Either direct applica-
tion of H2O2 or exposure of the cells to 6 h of hypoxia, 1 %
O2, followed by 16 h of normoxia significantly increased the
expression of mRNA for AE2 and NHE1. Furthermore, using
a luciferase reporter gene construct, it was also shown that the
activity of the NHE1 promoter was increased by hypoxia/
reoxygenation. These observations accord with those of Lam
et al. [41] who found increased Na+/H+ exchange activity
following exposure to hypoxia for 30 min in cortical micro-
vascular endothelial cells. If such changes were to occur
in vivo, the greater activities of NHE1 and AE2 would be
expected to increase the net transport of Na+ and HCO3
− into
the brain. This could have implications for ion transport/fluid
secretion at the blood–brain barrier following ischaemia (see
final section).
A current model of ion transport at the blood–brain barrier
The ion transporters identified in the present study may be
inserted into the current model of blood–brain barrier trans-
port as shown in Fig. 8. The primary route for Na+ entails
entry from the blood via NKCC1 [26, 54, 72]; however some
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must also enter in conjunction with HCO3
− transport. Net exit
of Na+ into the brain occurs primarily via Na+, K+–ATPases
[5, 6, 25, 26, 48, 65], but possibly some Na+ could exit by
cotransport with HCO3
−. HCO3
− can enter the cell from the
blood directly by one or both of the NBCs identified here, i.e.
NBCe1 (in its 2 HCO3
− to 1 Na+ mode) or NBCn1. It can also
enter indirectly by diffusion of CO2, its hydration to carbonic
acid catalyzed by carbonic anhydrase, dissociation of that to
form H+ and HCO3
− and transport of the H+ to the blood via
NHE1 and possibly NHE2. Under unchallenged conditions
where endothelial cell pHi is >7, Na
+/H+ exchange and thus
CO2 hydration are relatively unimportant [49], which can ex-
plain the lack of inhibition by acetazolamide (an inhibitor of
carbonic anhydrase) of blood–brain barrier secretion observed
in vivo (see page 739 in [21]). When pHi is reduced, as occurs
under ischaemic conditions, Na+/H+ exchange then becomes
important [49], and as shown here NHE1 mediates at least part
of this activity. Net exit of HCO3
− into the brain may occur via
Cl−/HCO3
− exchange mediated by AE2 and possibly via
NBCe1 (in 1 Na+/3 HCO3
− mode as in renal proximal tubules
[64, 70, 83] and as shown for NBCe2 in choroid plexus [18]).
Cl− enters the endothelial cells from the blood via NKCC1
and, if internal Cl− is less than about 95 mM, will also enter
the cells via AE2. It may leave into the brain by as yet
unidentified Cl− channels or K+, Cl− cotransporters. A
volume-activated Cl− channel has been found in these cells
[80], which, though unlikely to be the route for Cl− exit in the
absence of cell swelling, may be important in Cl− transport
during ischaemia. More Cl− enters cells across the luminal
membrane via NKCC1 than is transported across to the brain,
so at least some must exit on the luminal side. Thus, there
must be an as yet unidentified route for Cl− to leave cells on
the blood side and again the suggested routes are channels and
K+, Cl− cotransporters.
As indicated in Fig. 8, K+ can enter via NKCC1 on the
luminal side and via the Na+ pump on the abluminal side [26],
in both cases in much larger amounts than are transported
across the endothelium. Thus, there must be routes for K+
recycling across both membranes [47], which could be K+
channels, some of which are known to be present,2 or possi-
bly K+ , Cl− cotransporters. The presence of passive transport
routes for K+ in both membranes is consistent with observa-
tions that the K+ permeability of the blood–brain barrier
in vivo is ca. tenfold higher than the permeability to Na+ or
Cl− [22, 69].3
The importance of blood–brain barrier ion transport
Under normal conditions, ion transport and relatively high
water permeability across the blood–brain barrier are impor-
tant in helping to determine the ionic composition and volume
of the ISF. The net flow of fluid produced also aids in the
removal of high molecular weight blood–brain barrier
impermeant materials from the brain. [17].
However, following ischaemia, uptake and release of ions
by cells within the brain are also important in determining the
composition and volume of the ISF. Within a few minutes of
onset of ischaemia, there is generation of non-volatile acid and
consequent decrease in both intracellular and ISF pH, net
cellular uptake of Na+ and Cl− and release of K+, cell swelling
and decreased ISF volume [24, 38, 43, 67, 73]. Nevertheless,
for the total volume to increase, i.e. for there to be oedema, the
ISF must be replenished by a rate of fluid secretion across the
blood–brain barrier that exceeds the rate of fluid loss from the
brain [4]. The rate of loss will be reduced from its pre-
ischaemic value by the decreased size of interstitial spaces
[67], and furthermore the rate of secretion is increased [7, 14].
While continued or increased transport across the blood–
brain barrier during ischaemia may be beneficial in countering
changes in interstitial K+ concentration and pH, secretion of
Na+ and Cl− will contribute to oedema. Thus, in targeting the
blood–brain barrier to reduce the effects of ischaemia, it would
be desirable to inhibit Na+ and Cl− secretion while not
impairing or even increasing the transport of K+ from the
brain and the secretion of HCO3
− into the brain. Of the
transport activities now known to exist in the endothelial cells,
2 There is evidence for several types of K+ channel in brain endothelial
cells, though some is contradictory. Thus, Hoyer et al. [31] found inward-
ly rectifying K+ channels on the abluminal membrane, a location well
suited to recycling K+ that entered the cells via Na+, K+–ATPase; Millar
et al. [47] found both mRNA and functional fingerprints for Kv1 andKir2
channels but not Ca2+-activated channels; and van Renterghem et al. [78]
and Chen et al. [13] found Ca2+-activated channels. The differences may
be the result of different experimental conditions for the patch-clamp
experiments used to identify the channels. Regardless, the available
evidence indicates that there are several possible routes for K+ efflux
from brain endothelial cells.
3 Despite widespread acceptance of the view that net movement of K+
across the blood–brain barrier is from brain to blood, see e.g. [52], the
direction of this net movement has not been established and may vary. K+
concentration is less in ISF than in plasma (see [21] for a review); this has
been taken as evidence that K+ must be actively transported from brain to
blood across the blood–brain barrier. However, if K+ is removed from the
brain via ISF outflow, then at steady state K+ concentration within ISF is
determined by the ratio of the net rates at which K+ and volume are added
to the brain compartment by all other routes to replace materials removed
via the outflow. Thus, to achieve a lower ISF K+ concentration, there is no
need that K+ be transported back to the blood by an active process.
A more subtle argument can be based on the data of Bito and
Davson [8] who found that the K+ concentration of CSF in the cortical
subarachnoid spaces, 2.65 ±0.1mequiv/kgH2O, is lower than that of CSF
in the cisterna magna, 2.98±0.06 mequiv/kg H2O (data for dogs, with
similar results for cats). They took this observation to imply that K+ was
being removed from the CSF by diffusion into the cortical parenchyma as
the CSF flowed from the cisterna magna to the subarachnoid spaces. This
removal could be sustained at steady state if there were net K+ transport
out of the ISF across the blood–brain barrier. However, again there are
alternative explanations. Thus, the CSF K+ concentration could also be
reduced if fluid with a lower K+ concentration were added to the CSF
during passage from cisternae to subarachnoid space.
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if they were to be distributed as shown in Fig. 8, the most
appropriate target for inhibition would be NKCC1. Inhibiting
this transporter would reduce the movements of Na+, K+ and
Cl− towards the brain without directly impairing secretion of
HCO3
− or removal of H+. Indeed marked reduction in oedema
and infarct size following middle cerebral artery occlusion in
the rat has been seen with bumetanide, an inhibitor of NKCC1
[52, 54].
The NHE1 and NHE2 inhibitor, cariporide, has also been
shown to reduce oedema and infarct size following middle
cerebral artery occlusion [53]. If its action is on secretion
across the blood–brain barrier, then it must be inhibiting,
directly or indirectly, both Na+ and Cl− movements towards
the brain. Such inhibition would occur if both the Na+/H+
exchanger, NHE1 or NHE2, and Cl−/HCO3
− exchanger, AE2,
were located in the luminal membrane of the endothelial cells
as suggested by O'Donnell [52]. Direct NHE inhibition would
lead to a decrease in intracellular pH and HCO3
− concentra-
tion, which would in turn reduce Cl−/HCO3
− exchange, with
the net effect of reducing NaCl entry across the luminal
membrane. However, while placing AE2 in the luminal mem-
brane is consistent with the data for Cl−/HCO3
− exchange in
cultured brain endothelial cells [49, 76], it is not consistent
with the proposed role for AE2 in normal secretion across the
blood–brain barrier: Cl−/HCO3
− exchange across the luminal
membrane would oppose the net secretion of HCO3
−. There
are several possible resolutions of this inconsistency: a mech-
anism other than Cl−/HCO3
− exchange by AE2 accounts for
either entry of Cl− to the cells during ischaemia or exit of
HCO3
− in normal secretion4; AE2 may relocate from
abluminal to luminal membranes during ischaemia; cariporide
may not be having its effects via inhibition of NHE in the
endothelium but rather by inhibition of NHE in cells within
the brain parenchyma. This last option is also pertinent to
interpretation of the in vivo effects of bumetanide as discussed
earlier.
NKCC1 and the NHEs are known to be present on
neurons and astrocytes within the brain parenchyma. If
inhibitors of these transporters reach the parenchyma,
they will produce marked reductions in the responses of
the parenchymal cells to ischaemia with less cellular
uptake of Na+ and Cl−, less release of K+, reduced cell
swelling [12, 36, 56, 71, 81, 82] and presumably also
less contraction of the interstitial spaces. These inhibitor
effects within the parenchyma may have consequences
quite independently of any direct effects of the inhibitors
on the endothelial cells that counter changes in the rates








































blood endothelial cell interstitial fluidFig. 8 Schematic diagram of the
transporters putatively involved
in movement of ions across the
blood–brain barrier. Transporters
drawn as solid lines are already
identified and with known
locations, those shown as dashed
lines are already identified but
with suggested locations and
those drawn as dotted lines
indicate possible activities in the
membranes indicated. Some
route/s in addition to those shown
solid or dashed must exist in each
membrane for each of K+ and Cl−.
Transporter names are defined in
the tables. Transported species are
indicated at the source end of each
arrow. NHE is shown in both
membranes [41, 53]
4 It has already been noted that there must be on the luminal membrane at
least one unidentified route, which cannot be AE2, to allow recycling of a
portion of the Cl− that enters via NKCC1. Similarly, there may be
alternatives to AE2 for the HCO3
− efflux to the brain.
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without the inhibitors (see e.g. [66, 67]). Whether or not
the inhibitors reach sites within the parenchyma in suf-
ficient concentrations is at present unknown,5 and it is
prudent to regard the reductions in the extent of oedema
and infarct volume as results of effects on both the
endothelial cells and parenchymal cells. The relative
importance of these sites of action may be different for
bumetanide and cariporide.
In summary, results of the current study identify AE2,
NBCn1 and NBCe1 on microvessels in the brain. Experi-
ments on endothelial cells in culture demonstrate that these
transporters can make a substantial contribution to movement
of ions into and out of the endothelium. Further work is now
required to determine the localization of these bicarbonate
transporters to luminal or abluminal membranes of the endo-
thelial cells as noted by O'Donnell [52] as well as to identify
and localize additional transport mechanisms that must exist
for K+ and Cl−.
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